Overview: The role of radiation therapy in the treatment of pediatric Hodgkin lymphoma has
continued to be refined, motivated by the desire to avoid disruption to normal tissue …

Background The event‐free survival (EFS) of children with Hodgkin lymphoma (HL) exceeds
80% in high income countries (HIC), but little is known about this rate in developing …

Clinical stage alone is used for risk stratification in treatment of pediatric advanced Hodgkin
lymphoma (HL). To identify other risk factors, we collected data from three tertiary centers on …

Background As Hodgkin lymphoma (HL) is a highly curable malignancy, most current
pediatric trials focus on strategies aimed at reducing late effects of therapy. We report our …

Purpose To evaluate whether clinical risk factors could further distinguish children with
intermediate-risk Hodgkin lymphoma (HL) with rapid early and complete anatomic response …

Importance To date, there is no well-defined standard of care for early-stage pediatric
Hodgkin lymphoma (HL), which may include chemotherapy alone or combined modality …

The prognosis of Hodgkin's lymphoma (HL) in pediatric patients (pts) with current combined
chemoradiotherapy regimens in general is excellent. Even those pts suffering from recurrent …

Abstract BACKGROUND: Pediatric Hodgkin lymphoma (HL) is a highly curable disease;
however, prognostic factors for the survival of patients who develop recurrent disease have …

Therapy results in pediatric Hodgkin lymphoma reflect remarkable progress in pediatric
oncology. In the last decade, relevant development of new therapeutic options for children …

Historically, both adult and childhood Hodgkin lymphoma (HL) were treated with full-dose
(35-45 Gy) extended-field radiation therapy (RT). Although this treatment was the first to …